Loading...

Home
ETF
ALXO

ALXO

-

$

0.000

0.000(0.000%)

At close

0.000(0.000%)Aft-market

ET

$

0.000

0.000(0.000%)

At close

0.000(0.000%)Aft-market

ET

Overview Technical News

Most Trusted AI Platform for Winning Trades

Copyright © 2026 Intellectia.AI. All Rights Reserved.

Company

Home
Contact
About Us
Press
Privacy
Terms of Service
Service Terms of Use

Resources

Blog
Tutorial
Help Center
Affiliate Program

Markets

Market Analysis
Crypto
Featured Screeners
AI Earnings Calendar
Market Movers
Stock Monitor
Economic Calendar
All US Stocks
All Cryptos

Tools

Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator

Features

QuantAI Alpha Pick
SwingMax Portfolio
Swing Trading
AI Stock Picker
Whales Auto Tracker
Daytrading Center
Patterns Detection
AI Screener
Financial AI Agent
Backtesting Playground
AI Earnings Prediction
Stock Monitor
Technical Analysis

News

Overview
Top News
Daily Market Brief
Earnings Analysis
Newswire
Stock News
Crypto News
Institution News
Congress News
Monitor News

Compare

TradingView
SeekingAlpha

ALXO News

ALX Oncology Q1 Earnings Beat Expectations

2d agoseekingalpha

ALX Oncology Presents Promising Evorpacept Data at ESMO Breast Cancer 2026

2d agoNewsfilter

ALX Oncology Q1 2026 Earnings Call Insights

1d agoseekingalpha

ALX Oncology Grants Stock Options to New COO

Apr 17 2026Newsfilter

ALX Oncology Appoints New Chief Development Officer

Apr 13 2026Newsfilter

ALX Oncology Q4 2025 Earnings Call Highlights

Feb 27 2026seekingalpha

ALX Oncology Q4 Earnings Miss Expectations, Shares Rise on Offering

Feb 27 2026seekingalpha

ALX Oncology Reports Clinical Progress and Financial Update

Feb 27 2026Newsfilter

ALX Oncology to Participate in Multiple Biotech Summits

Feb 19 2026Newsfilter

ALX Oncology Shares Surge 10% After Major VC Purchase

Feb 04 2026seekingalpha

ALX Oncology Announces Pricing of Underwritten Offering

Feb 02 2026NASDAQ.COM

ALX Oncology Prices Underwritten Stock Offering

Jan 30 2026seekingalpha

ALX Oncology Prices $150 Million Stock Offering to Fund Cancer Therapies

Jan 30 2026Newsfilter

ALX Oncology's New Data Reinforces CD47 Biomarker Significance

Jan 30 2026Newsfilter

ALX Oncology to Present at 44th Annual J.P. Morgan Healthcare Conference on January 15, 2026

Jan 08 2026Globenewswire

ALX Oncology Gains 10.17% on Positive Phase 2 Trial Data for Evorpacept

Jan 08 2026NASDAQ.COM